The DEA Registration Process for Cannabis Businesses: What Operators Need to Know in 2026
The federal cannabis landscape shifted significantly in April 2026 when the Drug Enforcement Administration, under direction from the U.S. Department of Justice, issued a final order moving certain cannabis products, primarily those tied to state medical programs, into Schedule III of the Controlled Substances Act. For any cannabis operator working with a seasoned business lawyer, this development introduces a new federal compliance pathway for qualifying medical cannabis operators, particularly for those navigating complex regulatory environments with a New York cannabis business lawyer.
While this change stops short of federal legalization, it creates, for the first time, a formal DEA registration process for cannabis businesses operating within the medical framework.
Read More